Nevro Corp
(NVRO)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Sales | 105,548 | 96,910 | 104,161 | 101,899 | 116,176 |
| Cost of Goods | 39,629 | 32,296 | 36,694 | 30,371 | 34,699 |
| Gross Profit | 65,919 | 64,614 | 67,467 | 71,528 | 81,477 |
| Operating Expenses | 117,956 | 78,776 | 93,282 | 107,733 | 93,963 |
| Operating Income | -51,408 | -13,866 | -25,121 | -35,834 | -11,787 |
| Interest Expense | 6,626 | 7,008 | 6,741 | 6,512 | 3,165 |
| Other Income | 5,092 | 5,810 | 12,549 | 17,319 | -607 |
| Pre-tax Income | -52,942 | -15,064 | -19,313 | -25,027 | -15,559 |
| Income Tax | 169 | 280 | 262 | 382 | -6,578 |
| Net Income Continuous | -53,111 | -15,344 | -19,575 | -25,409 | -8,981 |
| Net Income | $-53,111 | $-15,344 | $-19,575 | $-25,409 | $-8,981 |
| EPS Basic Total Ops | -1.42 | -0.41 | -0.53 | -0.70 | -0.24 |
| EPS Basic Continuous Ops | -1.42 | -0.41 | -0.53 | -0.70 | -0.24 |
| EPS Diluted Total Ops | -1.42 | -0.41 | -0.53 | -0.70 | -0.24 |
| EPS Diluted Continuous Ops | -1.42 | -0.41 | -0.53 | -0.70 | -0.24 |
| EPS Diluted Before Non-Recurring Items | -0.64 | -0.51 | -0.43 | -0.70 | -0.15 |
| EBITDA(a) | $-9,639 | $-10,527 | $-21,662 | $-32,110 | $-9,415 |